News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Drug Prices Down For Patients

New Zealanders will find a range of prescription drugs costing them less as a result of the latest tender round announced by PHARMAC today.

PHARMAC CEO Wayne McNee says so far this year tenders have been awarded on more than 70 pharmaceuticals, involving 39 chemicals and will bring estimated savings of $22.5 million over three years.

“A very positive outcome of these tender results is that 25 chemicals that previously had a manufacturers surcharge (part charge) will now be fully subsidised for the next three years.”

Some of the key results of the tender are a contraceptive injection which now becomes fully subsidised as well as three antibiotics, in particular one liquid for children.

Wayne McNee says PHARMAC is particularly pleased that a tender agreement has ensured that two pharmaceuticals used for the treatment of high blood pressure and congestive heart failure will remain fully subsidised for the next three years. The drugs are ACE Inhibitors enalapril and captopril.

He says that some New Zealanders taking ACE Inhibitors may notice that the drugs they are prescribed look a little different due to a change in brand.

“The same chemicals will be available but they might have different names. A doctor can prescribe by chemical name to ensure the patient receives their prescription fully funded.”

Wayne McNee says the cost savings achieved by PHARMAC for these drugs is a real success story for the taxpayer and the health system. It allows the savings made to be redistributed for the funding of other pharmaceuticals.

“One ACE Inhibitor, enalapril, will now cost 4 cents a day compared to the 90 cents a day it cost taxpayers just three years ago. ACE inhibitors used to cost the New Zealand taxpayer $70 million market – and that will drop to $7 million, even though the number of patients being treated has risen and is expected to continue to do so.”

Wayne McNee says these savings allow more spending on other drugs such as cholesterol lowering medication as well as other health care.

“PHARMAC is doing its job. It is making funds available for the health sector at the same time as ensuring New Zealanders continue to have access to the best possible range of drugs.”


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>

Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>


Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>